© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 30, 2021
A key opinion leader considers the benefits of combining pharmacologic and nonpharmacologic treatments in the management of attention-deficit/hyperactivity disorder (ADHD) in children.
Theresa R. Cerulli, MD, reviews the use of viloxazine in managing pediatric attention-deficit/hyperactivity disorder (ADHD).
November 23, 2021
A neuropsychiatrist shares her thoughts on the relationship between substance abuse and attention-deficit/hyperactivity disorders (ADHD) in the pediatric population.
Theresa R. Cerulli, MD, describes the challenges comorbid psychiatric conditions pose in diagnosing attention deficit hyperactivity disorders (ADHD).